Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of a multiplex PCR screening approach to identify community-acquired bacterial co-infections in COVID-19: a multicenter prospective cohort study of the German competence network of community-acquired pneumonia (CAPNETZ).
Rothe K, Spinner CD, Panning M, Pletz MW, Rohde G, Rupp J, Witzenrath M, Erber J, Eberhardt F, Essig A, Schneider J; Members of the CAPNETZ study group. Rothe K, et al. Among authors: spinner cd. Infection. 2021 Dec;49(6):1299-1306. doi: 10.1007/s15010-021-01720-8. Epub 2021 Oct 23. Infection. 2021. PMID: 34687426 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 38980614
Systematic assessment of COVID-19 host genetics using whole genome sequencing data.
Schmidt A, Casadei N, Brand F, Demidov G, Vojgani E, Abolhassani A, Aldisi R, Butler-Laporte G; DeCOI host genetics group; Alawathurage TM, Augustin M, Bals R, Bellinghausen C, Berger MM, Bitzer M, Bode C, Boos J, Brenner T, Cornely OA, Eggermann T, Erber J, Feldt T, Fuchsberger C, Gagneur J, Göpel S, Haack T, Häberle H, Hanses F, Heggemann J, Hehr U, Hellmuth JC, Herr C, Hinney A, Hoffmann P, Illig T, Jensen BO, Keitel V, Kim-Hellmuth S, Koehler P, Kurth I, Lanz AL, Latz E, Lehmann C, Luedde T, Maj C, Mian M, Miller A, Muenchhoff M, Pink I, Protzer U, Rohn H, Rybniker J, Scaggiante F, Schaffeldt A, Scherer C, Schieck M, Schmidt SV, Schommers P, Spinner CD, Vehreschild MJGT, Velavan TP, Volland S, Wilfling S, Winter C, Richards JB; DeCOI; Heimbach A, Becker K, Ossowski S, Schultze JL, Nürnberg P, Nöthen MM, Motameny S, Nothnagel M, Riess O, Schulte EC, Ludwig KU. Schmidt A, et al. Among authors: spinner cd. PLoS Pathog. 2024 Dec 23;20(12):e1012786. doi: 10.1371/journal.ppat.1012786. Online ahead of print. PLoS Pathog. 2024. PMID: 39715278 Free article.
Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals.
Spinner CD, Bell S, Einsele H, Tremblay C, Goldman M, Chagla Z, Finckh A, Edwards CJ, Aurer I, Launay O, Casañas I Comabella C, James S, Dube S, Borkowska K, Jah F, Kandeil W, Yokota RTC, Artaud C, Gottenberg JE, Gesualdo L, Bertrand D, Arnetorp S, Magiorkinis G. Spinner CD, et al. Adv Ther. 2024 Dec 16. doi: 10.1007/s12325-024-03043-0. Online ahead of print. Adv Ther. 2024. PMID: 39680311 Review.
Implementation and User Satisfaction of a Comprehensive Telemedicine Approach for SARS-CoV-2 Self-Sampling: Monocentric, Prospective, Interventional, Open-Label, Controlled, Two-Arm Feasibility Study.
Voit F, Erber J, Egert-Schwender S, Hanselmann M, Laxy M, Kehl V, Hoffmann D, Jeske SD, Michler T, Protzer U, Kohlmayer F, Schmid RM, Spinner CD, Weidlich S. Voit F, et al. Among authors: spinner cd. JMIR Form Res. 2024 Dec 11;8:e57608. doi: 10.2196/57608. JMIR Form Res. 2024. PMID: 39661941 Free PMC article. Clinical Trial.
Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort study.
Stephan C, Spinner CD, Rieke A, Christensen S, Mauss S, Schreiber S, Albuquerque B, Heinzkill M, Ramroth H, Stellbrink HJ. Stephan C, et al. Among authors: spinner cd. HIV Med. 2024 Oct 30. doi: 10.1111/hiv.13728. Online ahead of print. HIV Med. 2024. PMID: 39476488
Characterising HIV-Indicator conditions among two nationwide long-term cohorts of people living with HIV in Germany (1999-2023).
Krings A, Kollan C, Schmidt D, Gunsenheimer-Bartmeyer B, Valbert F, Neumann A, Wasem J, Behrens GMN, Bickel M, Boesecke C, Esser S, Dröge P, Ruhnke T, Koppe U; HIV-1 Seroconverter, ClinSurv-HIV study groups. Krings A, et al. Infection. 2024 Oct 30. doi: 10.1007/s15010-024-02419-2. Online ahead of print. Infection. 2024. PMID: 39476279
Evaluation of a host-protein signature score for differentiating between bacterial and viral infections: real-life evidence from a German tertiary hospital.
Wagner L, Schneider H, Luppa PB, Schröder K, Wantia N, Querbach C, Jeske SD, Lahmer T, Rothe K, Dibos M, Voit F, Erber J, Spinner CD, Schneider J, Triebelhorn J. Wagner L, et al. Among authors: spinner cd. Infection. 2024 Sep 9. doi: 10.1007/s15010-024-02384-w. Online ahead of print. Infection. 2024. PMID: 39249176
Tixagevimab/Cilgavimab for COVID-19 Pre-Exposure Prophylaxis in Hematologic Patients-A Tailored Approach Based on SARS-CoV-2 Vaccine Response.
Braitsch K, Jeske SD, Stroh J, Hefter M, Platen L, Bachmann Q, Renders L, Protzer U, Götze KS, Herhaus P, Verbeek M, Spinner CD, Bassermann F, Högner M, Haller B, Schneider J, Heider M. Braitsch K, et al. Among authors: spinner cd. Vaccines (Basel). 2024 Aug 1;12(8):871. doi: 10.3390/vaccines12080871. Vaccines (Basel). 2024. PMID: 39203997 Free PMC article.
172 results